A Study to Determine the Bioavailability of Various Formulations of GDC-0134 in Healthy Female Participants of Non-Childbearing Potential

NCT03807739 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: GDC-0134 F09 Formulation
DRUG: GDC-0134 F15 Formulation
DRUG: GDC-0134 F16 Formulation

Sponsor

Genentech, Inc.